Drugs / XYWAV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06421532 | Mar 2025 → Sep 2027 expected | cerebral amyloid angiopathy | Leiden University Medical Center | Enrolling by invitation | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | XYWAV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06421532 ↗ |